Tempus
New Products Posted to GenomeWeb: Tempus, GenScript, RealSeq Biosciences, 23andMe
New products and services posted to GenomeWeb for the week of June 19, 2023
People in the News at Tempus, Oncocyte, Guardant Health, National Academy of Sciences, 23andMe, More
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of May 8, 2023.
Companies that built their business in tissue and blood-based DNA analyses are now exploring imaging technologies across a variety of fronts.
Pfizer Partners With Tempus to Advance Oncology Drug Development
Pfizer will have access to Tempus' artificial intelligence-powered platform, data library, companion diagnostics platform, and clinical trial matching program.
Tempus, Actuate Therapeutics Ink Collaboration to Discover Biomarkers of Response for Elraglusib
Tempus will provide its clinical xF+ liquid biopsy and research-use-only DNA methylation tests to the ongoing Phase I/II trial of Actuate's GSK-3β inhibitor elraglusib.